Thomas Greiner-Stöffele
Keine laufenden Positionen mehr
Profil
Thomas Greiner-Stöffele was the founder of c-LEcta GmbH, where he held the title of Chief Scientific Officer from 2009 to 2010.
He also worked as a Principal at Max-Planck-Institute for Molecular Genetics and Universität Leipzig.
At Universität Leipzig, he held the title of Principal in 2008.
Dr. Greiner-Stöffele received his undergraduate and doctorate degrees from Universität Leipzig.
Ehemalige bekannte Positionen von Thomas Greiner-Stöffele
| Unternehmen | Position | Ende |
|---|---|---|
| Universität Leipzig | Corporate Officer/Principal | 01.01.2008 |
| Max-Planck-Institute for Molecular Genetics | Corporate Officer/Principal | - |
c-LEcta GmbH
 c-LEcta GmbH BiotechnologyHealth Technology c-LEcta GmbH operates as a industrial biotechnology company that discovers, optimizes, produces, and sells enzymes for research, development, bio-catalysis, diagnostics, and industrial applications. The firm focuses on the utilization of proteins with catalytic properties. It offers recombinant RNases, exonucleases, alcohol-dehydrogenases, lipases, and proteases for applications in research and development; biocatalysts for the production of chemicals; and starch, cellulose, and hemicellulose hydrolyzing enzymes, as well as lipases and proteases to use as components in detergents and cleaning products for the food and feed industry. The company was founded by Marc Struhalla and Thomas Greiner-St?ffele in 2004 and is headquartered in Leipzig, Germany. | Gründer | - |
Ausbildung von Thomas Greiner-Stöffele
| Universität Leipzig | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
c-LEcta GmbH
c-LEcta GmbH BiotechnologyHealth Technology c-LEcta GmbH operates as a industrial biotechnology company that discovers, optimizes, produces, and sells enzymes for research, development, bio-catalysis, diagnostics, and industrial applications. The firm focuses on the utilization of proteins with catalytic properties. It offers recombinant RNases, exonucleases, alcohol-dehydrogenases, lipases, and proteases for applications in research and development; biocatalysts for the production of chemicals; and starch, cellulose, and hemicellulose hydrolyzing enzymes, as well as lipases and proteases to use as components in detergents and cleaning products for the food and feed industry. The company was founded by Marc Struhalla and Thomas Greiner-St?ffele in 2004 and is headquartered in Leipzig, Germany. | Health Technology |
